BioNTech SE (BNTX) Short term Debt (2018 - 2025)

BioNTech SE has disclosed Short term Debt across 8 years of filings, most recently posting $409.4 million for Q4 2025.

• Short term Debt for Q4 2025 came in at $409.4 million, down 73.46% year-over-year; the trailing twelve-month figure through Dec 2025 was $409.4 million (down 73.46% YoY), and the FY2025 annual result was $397.4 million, down 74.24% from the prior year.
• Short term Debt came in at $409.4 million for Q4 2025 at BioNTech SE, down from $698.4 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $1.6 billion in Q1 2022 to a low of $37.3 million in Q3 2022.
• The 5-year median for Short term Debt is $428.1 million (2023), against an average of $573.9 million.
• Across the five-year window, Short term Debt jumped 12451.18% in 2021 and sank 78.19% in 2023, its largest moves.
• BioNTech SE's Short term Debt stood at $1.4 billion in 2021, then tumbled by 41.18% to $801.0 million in 2022, then plunged by 44.23% to $446.7 million in 2023, then soared by 245.27% to $1.5 billion in 2024, then sank by 73.46% to $409.4 million in 2025.
• The last three Short term Debt figures came in at $409.4 million (Q4 2025), $698.4 million (Q3 2025), and $164.1 million (Q2 2025), per Business Quant data.